AL
Therapeutic Areas
Artificial Axon Labs Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Remyelination Drug Discovery | Multiple Sclerosis | Pre-clinical |
Leadership Team at Artificial Axon Labs
AJ
Anna Jagielska, PhD
Founder, CEO/President
KK
Kavin Kowsari, PhD
Founder, CTO
KJ
Krystyn J. Van Vliet, PhD
Scientific Co-Founder
NX
Nicholas X. Fang, PhD
Scientific Co-Founder
AV
Anna Voronova, PhD
Strategic Advisor
NT
Nicholas Terrett, PhD
Medicinal Chemistry